This inventor holds 1 USPTO granted patent. Top assignee: Warner-Lambert Company. Active years: 2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2002
Title: The Innovations of Michael Forster
Introduction
Michael Forster is an accomplished inventor based in Fort Worth, TX (US). He is known for his significant contributions to the field of pharmaceuticals, particularly in the development of new drug formulations. His work has led to advancements that aim to improve patient outcomes and reduce side effects associated with existing medications.
Latest Patents
One of Michael Forster's notable patents is for (−)-Pseudoephedrine as a sympathomimetic drug. This invention provides pharmaceutical compositions that include (−)-pseudoephedrine and a pharmaceutically acceptable carrier. The key feature of this invention is that the (−)-pseudoephedrine is substantially free of (+)-pseudoephedrine. Additionally, the patent outlines methods for relieving nasal and bronchial congestion and inducing pupil dilation by administering a pharmaceutically effective amount of (−)-pseudoephedrine to a mammal. This formulation aims to minimize the side effects typically associated with the administration of (+)-pseudoephedrine.
Career Highlights
Michael Forster has made significant strides in his career, particularly through his work at Warner-Lambert Company. His innovative approach to drug formulation has garnered attention in the pharmaceutical industry. With a focus on improving the efficacy and safety of medications, Forster has established himself as a key figure in pharmaceutical research and development.
Collaborations
Throughout his career, Michael has collaborated with notable colleagues, including Peter Raven and James L. Caffrey. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.
Conclusion
Michael Forster's contributions to the field of pharmaceuticals, particularly through his patent on (−)-Pseudoephedrine, highlight his commitment to innovation and improving patient care. His work continues to influence the pharmaceutical landscape, paving the way for safer and more effective treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile